Cases 11 - 14 of 14
Novartis Pharmaceuticals Corporation et al v. Watson Laboratories, Inc. et al
as 1:2011cv08130
Plaintiff:
Novartis Pharmaceuticals Corporation , Novartis AG , Novartis Pharma AG and others
Defendant:
Watson Laboratories, Inc., Watson Pharma, Inc. and Watson Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation et al v. Alembic Pharmaceuticals Limited et al
as 1:2011cv07092
Plaintiff:
Novartis Pharmaceuticals Corporation , Novartis AG , Novartis Pharma AG and others
Defendant:
Alembic Pharmaceuticals Limited, Alembic Pharma Limited, Alembic Limited and others
Cause Of Action: 35 U.S.C. § 271
Murphy v. Novartis AG et al
as 3:2010cv01053
Plaintiff:
Michael Murphy
Defendant:
Novartis AG , Novartis Pharma AG and Novartis Pharmaceuticals Corp
Cause Of Action: 28 U.S.C. § 1332
In Re: Rivastigmine Patent Litigation
as 1:2005md01661
Plaintiff:
Novartis Pharmaceuticals Corporation, Novartis Pharmaceuticals Corporation, Novartis Pharmaceuticals Corporation and others
Defendant:
Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc., Sun Pharmaceutical Industries Ltd. and others
Counter Claimant:
Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.
Counter Defendant:
Novartis AG, Novartis Pharma AG, Novartis International Pharmaceutical Ltd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
